Microalgae as Aquaculture Feed: Replacing Fishmeal at the Base of the Chain

The Specific Question: Can Algae Replace What the Ocean Took to Make?

The question is not whether microalgae can replace fishmeal. The question is which components of fishmeal microalgae can replace, at what cost per kilogram of those components, and on what timeline. These are three separate questions, and the answers are different for each.

Fishmeal supplies three things that matter to a feed formulator: crude protein at 65-72 percent of dry weight with an amino acid profile closely matched to carnivorous fish physiology; long-chain omega-3 fatty acids (DHA and EPA) carried primarily in fish oil co-produced during the rendering process; and a palatability and digestibility profile that decades of farmed salmon and shrimp performance data has been calibrated against. Replacing all three from a single algae biomass source is not possible in 2026. Replacing the omega-3 fraction from heterotrophically fermented algal oil is commercially viable now. Replacing the protein fraction at competitive cost is not yet viable at commodity scale but is the trajectory for the 2030s.

The people asking this question most urgently are salmon feed mill operators in Norway, Chile, and Scotland, and shrimp feed compounders in Thailand, Vietnam, and Ecuador. The fishmeal price trajectory has made this a cost risk management problem, not just an environmental preferences exercise. The IFFO price index shows fishmeal from Peru trading at a 2.4x premium over 2000 prices in constant terms. Algal oil from Schizochytrium is already in commercial salmon diets from Cargill, BioMar, and Mowi: the question at the feed mill level is not whether to include it but at what inclusion rate and under what supply contract terms.

The second audience is the IMTA system designer. In integrated multi-trophic aquaculture, microalgae sit at the base of the trophic chain as primary producers. Understanding how algae function as a feed input is directly connected to understanding how they function as a water quality component in the same system. The two roles are not identical, but the biology overlaps.

The Mechanism: Two Production Routes, Five Strains, One Feed Stack

Microalgae produce biomass via two fundamentally different metabolic routes, and the choice of route determines which strains are viable, what the capital and operating cost structure looks like, and which nutrients the biomass contains at commercially useful concentrations.

Phototrophic production requires light and CO2. The organism fixes carbon via photosynthesis. Open pond raceway systems are the lowest capital cost phototrophic route: shallow paddle-wheel-driven channels typically 0.3-0.5 metres deep, 1,000-10,000 square metres per pond, with biomass productivities of 20-30 tonnes per hectare per year for Spirulina and Chlorella in subtropical climates. Contamination by competing organisms is the key operational risk. Photobioreactors (PBR) are closed phototrophic systems, typically tubular or flat-panel designs, that eliminate contamination risk and allow higher biomass density (2-5 g/L versus 0.3-0.8 g/L in open ponds) at 5-10x higher capital cost per litre of culture volume. Nannochloropsis and Isochrysis are commercially produced in PBR for marine finfish larval rearing because contamination control is non-negotiable in hatchery environments.

Heterotrophic production replaces light with a carbon feedstock, typically glucose, sucrose, or glycerol. The organism ferments sugar in the dark in a closed bioreactor. Productivity is 10-100x higher than phototrophic routes (biomass density of 20-150 g/L depending on organism and substrate), and the process runs on industrial fermentation equipment that is already widely deployed and well understood in pharmaceutical and food ingredient manufacturing. Heterotrophic production does not work for organisms that are obligate photoautotrophs: Spirulina cannot ferment. It is the production route for Schizochytrium (and related thraustochytrids) and for certain Chlorella strains. The DSM-Evonik joint venture Veramaris operates the world's largest dedicated heterotrophic algal omega-3 facility in Blair, Nebraska, designed to produce 15,000 tonnes of algal oil per year using glucose from co-located corn wet mills. That facility brings the full logic of the heterotrophic route into sharp focus: proximity to cheap fermentable carbon, industrial fermentation scale, and co-location with the existing agricultural supply chain.

Strain selection is a function of target species and target nutrient. There is no single algae strain that covers all nutritional roles. A salmon feed formulator targeting omega-3 replacement uses Schizochytrium-derived algal oil. A shrimp producer looking for partial fishmeal protein replacement uses Spirulina or Chlorella at inclusion rates of 5-15 percent of diet dry matter. A shellfish or marine finfish hatchery operator uses Isochrysis galbana as a standard live or paste feed for larvae, a role in which it has been the industry norm for decades. The IMTA system designer often works with multiple strains simultaneously, particularly where phototrophic algae in the water column serve a dual role as water quality managers and feed precursors for filter feeders like mussels and oysters.

The Numbers: DHA Content, Cost per Kilogram, and the Gap That Is Closing

The cost gap between microalgae biomass and fishmeal is real, measurable, and narrowing. Peruvian fishmeal (65-68% crude protein, prime grade) traded at approximately USD 1,400-1,800 per tonne in 2024-2025. At 66 percent protein content, that represents USD 2.12-2.73 per kg of crude protein. Bulk dried Spirulina biomass from large Chinese and Indian producers trades at approximately USD 6,000-9,000 per tonne in wholesale volumes (500+ tonne contracts), representing USD 9-14 per kg of crude protein at 65 percent protein content. The protein cost ratio is roughly 4-6x in favour of fishmeal for the protein fraction.

The omega-3 fraction comparison is more favourable for algae. Fish oil from Peru carries approximately 20-30 percent EPA+DHA combined. At USD 1,800-2,500 per tonne for refined fish oil, the cost per kg of EPA+DHA is approximately USD 6-12. Schizochytrium-derived algal oil at full Veramaris production capacity is priced at approximately USD 12,000-18,000 per tonne, but the DHA content is approximately 50 percent of dry weight (35-55 percent range across strains and fermentation conditions), meaning the effective cost per kg of DHA delivered is USD 24-50. The ratio is still 3-6x in favour of fish oil, but the gap has closed meaningfully: Schizochytrium oil production cost has fallen approximately 40 percent between 2012 and 2022 based on industry cost-of-goods estimates, and further volume-driven reductions are projected as Blair NE reaches full output.

The Veramaris Blair NE facility is the clearest data point on what industrial-scale heterotrophic production looks like. The facility was commissioned by the DSM-Evonik joint venture (two industrial chemistry majors) and designed for 15,000 tonnes of algal oil annually, with adjacent corn wet mill glucose supply from ADM. The site selection was a deliberate logistics optimization: corn-derived glucose at commodity grain prices, existing large-vessel fermentation expertise in the regional industrial base, and direct access to North American salmon feed supply chains. Corbion's AlgaPrime DHA product (Schizochytrium-based, produced in Brazil) provides a second commercial reference point with documented inclusion in BioMar salmon diets at 20-30 percent fish oil replacement. Cellana, operating smaller-scale phototrophic PBR in Hawaii, targets the DHA market from Nannochloropsis but at lower production volumes suited to premium specialty diets. These three operations define the current commercial frontier, none of them operating at the scale of the global fishmeal trade (5-6 million tonnes per year), but all demonstrating the production economics that trajectory projects forward.

The Practitioner View: What Feed Mill Operators and Fish Farmers Actually Do

At a salmon feed mill, algae inclusion decisions are made against a specific reference: what does 1 kilogram of EPA+DHA in the final diet cost from each available source, and what is the supply contract certainty for that source over a 12-36 month planning horizon. Fishmeal and fish oil have the advantage of a large, liquid, well-priced spot market and a 30-year supply chain with established logistics. Algal oil has the advantage of a supply ceiling that does not exist and a price that has only declined over the last decade, but it operates on longer-term offtake contracts because production volumes are not yet large enough to support a spot market. Feed mills running algal oil inclusion at 20-30 percent of the fish oil fraction are typically locked into 2-3 year supply contracts with Veramaris or Corbion.

Inclusion rate decisions follow the performance data. Published trials from BioMar (Corbion AlgaPrime, Norwegian salmon, 2019-2022) documented equal growth performance, feed conversion ratio (FCR), and fillet DHA content at 30-50 percent replacement of fish oil with Schizochytrium-derived algal oil. A 2021 Cargill trial showed no performance loss in Atlantic salmon at 100 percent fish oil replacement for the DHA fraction when Schizochytrium algal oil was used (fish oil was retained for EPA supply, as algal oil carries limited EPA). This is the operational ceiling the industry is working from: fish oil replacement for DHA is functionally complete at scale. What remains is cost.

For shrimp operations, the picture is different. Shrimp require substantially less long-chain omega-3 per unit of bodyweight than salmon, which means the omega-3 case for algal oil is weaker in shrimp diets. Spirulina and Chlorella inclusion in shrimp feed at 5-10 percent of diet dry matter is well-documented in trials across Thailand, Vietnam, and Ecuador, with benefits primarily attributed to pigmentation (astaxanthin and phycocyanin), immune stimulation, and partial protein contribution rather than omega-3 supply. Commercial shrimp pellets from CP Foods, Uni-President, and Olmix already include Spirulina at 2-8 percent inclusion for these functional benefits.

For RAS (recirculating aquaculture system) operators, which is the dominant form for land-based IMTA systems, microalgae serve an additional function beyond feed: Chlorella and Nannochloropsis strains integrated into the biofilter or sidestream reactor of a RAS treat dissolved nitrogen by algal uptake, producing biomass that is then returned to the feed stream. This dual-function role, water treatment plus feed input, is the economics case that makes algae particularly attractive in closed recirculating systems. The biomass yield from wastewater treatment algal production is typically 3-8 tonnes per hectare per year lower than optimised production ponds, but the operating cost is partially offset by the avoided wastewater treatment cost.

ASC-certified salmon operations that use algal oil in place of fish oil can document a reduced fishmeal dependency index in their certification audit. The ASC Salmon Standard requires disclosure of the Fish In Fish Out (FIFO) ratio, the quantity of wild fish equivalent required to produce one unit of farmed salmon. Algal oil replaces the omega-3 fraction that drives the FIFO ratio upward without adding to the wild fish draw. This matters commercially because ASC-certified salmon commands 8-15 percent retail price premium in European supermarkets, and FIFO ratio reduction is increasingly a certification audit point that reviewers scrutinise.

Where It Fits: Algae at the Base of the IMTA Chain and the Substitute Stack

The fishmeal substitute problem has a stack structure, not a single solution structure. The stack consists of several parallel substitution routes, each addressing different components of fishmeal's functional role in a diet. Microalgae are one tier in that stack, not the whole stack. Black soldier fly larvae (BSFL) provide a protein-dominant fishmeal substitute at cost already approaching fishmeal in commercial BSFL operations, but with minimal omega-3 content. Single-cell protein (Unibio, Calysta FeedKind, based on methanotrophic bacteria) provides high digestibility protein from natural gas or CO2. Plant protein concentrates (soy, pea, canola) are the cheapest protein source but lowest in digestibility and absent in omega-3s. Microalgae are the only tier in the substitute stack that provides concentrated DHA at commercially meaningful levels. That functional specificity is what defines their role.

In the IMTA chain, microalgae sit at the primary producer position, trophic level 1. All other organisms in the IMTA stack consume or process materials from the level below. Phototrophic algae in the water column fix CO2 and dissolved inorganic nitrogen, producing biomass that filter feeders (mussels, oysters, clams) consume directly. The filter feeders are at trophic level 2. Finfish consuming pelleted feed sit at trophic level 3 or higher depending on the carnivory of the diet. When heterotrophically produced algal oil enters the pelleted feed for the finfish, the algae are not physically present in the IMTA pond, but they function as the nutrient foundation of the diet that feeds the apex trophic species. The feed chain and the IMTA trophic chain are two expressions of the same primary production logic.

The economics case for microalgae in the 2030s is not parity with fishmeal protein, which remains a harder target. It is parity for the omega-3 fraction at scale. The structural logic is: wild pelagic fish populations are at or near peak sustainable catch. Global aquaculture production is projected to grow by 30-40 million tonnes by 2050 to meet protein demand. Fishmeal and fish oil cannot scale with aquaculture demand. Microalgae, produced heterotrophically from fermentable carbon, can scale without a wild-catch ceiling. Veramaris projected at full Blair NE capacity represents enough DHA to displace a material fraction of fish oil use in Norwegian salmon farming alone. If a second equivalent facility is built, the commercial terms move further. The trajectory is a cost-down curve typical of fermentation biotechnology, where each doubling of cumulative production volume has historically delivered 15-25 percent cost reduction.

For the IMTA designer building from first principles, the practical implication is: incorporate algal production, either phototrophic or heterotrophic, into the system design at every scale where it is mechanically feasible. At hatchery scale, Isochrysis and Nannochloropsis live algae culture is standard and non-negotiable for marine finfish and shellfish larvae. At grow-out scale, phototrophic algae in sidestream raceways or integrated photobioreactors serve water treatment, reduce feed input per unit of saleable biomass, and provide the feedstock for filter feeders co-stocked in the system. At the feed sourcing level, specifying algal oil from Schizochytrium in the pelleted feed contract reduces the FIFO ratio and decouples the operation from the fishmeal price cycle that the fishmeal trap has made structurally expensive.